Annual Operating Expenses
$12.89 M
-$10.08 M-43.87%
December 31, 2023
Summary
- As of February 7, 2025, SLRX annual total operating expenses is $12.89 million, with the most recent change of -$10.08 million (-43.87%) on December 31, 2023.
- During the last 3 years, SLRX annual operating expenses has risen by +$5.28 million (+69.43%).
- SLRX annual operating expenses is now -67.95% below its all-time high of $40.23 million, reached on December 31, 2016.
Performance
SLRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$1.01 M
-$461.00 K-31.41%
September 30, 2024
Summary
- As of February 7, 2025, SLRX quarterly total operating expenses is $1.01 million, with the most recent change of -$461.00 thousand (-31.41%) on September 30, 2024.
- Over the past year, SLRX quarterly operating expenses has dropped by -$765.10 thousand (-43.19%).
- SLRX quarterly operating expenses is now -91.23% below its all-time high of $11.47 million, reached on June 30, 2016.
Performance
SLRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
SLRX Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -43.9% | -43.2% |
3 y3 years | +69.4% | -74.7% |
5 y5 years | -42.6% | -74.7% |
SLRX Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -43.9% | +0.6% | -84.5% | +3.7% |
5 y | 5-year | -43.9% | +69.4% | -84.5% | +3.7% |
alltime | all time | -68.0% | +69.4% | -91.2% | +3.7% |
Salarius Pharmaceuticals Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $1.01 M(-31.4%) |
Jun 2024 | - | $1.47 M(-17.2%) |
Mar 2024 | - | $1.77 M(+82.5%) |
Dec 2023 | $12.89 M(-43.9%) | $970.70 K(-61.7%) |
Sep 2023 | - | $2.53 M(-36.2%) |
Jun 2023 | - | $3.97 M(-26.7%) |
Mar 2023 | - | $5.42 M(-16.3%) |
Dec 2022 | $22.98 M(+79.3%) | $6.48 M(+15.2%) |
Sep 2022 | - | $5.62 M(+18.2%) |
Jun 2022 | - | $4.76 M(-22.2%) |
Mar 2022 | - | $6.12 M(+165.4%) |
Dec 2021 | $12.81 M(+68.4%) | $2.30 M(-38.5%) |
Sep 2021 | - | $3.75 M(+1.6%) |
Jun 2021 | - | $3.69 M(+20.0%) |
Mar 2021 | - | $3.07 M(-5.1%) |
Dec 2020 | $7.61 M(-35.1%) | $3.24 M(+3.3%) |
Sep 2020 | - | $3.14 M(+5.8%) |
Jun 2020 | - | $2.97 M(-15.3%) |
Mar 2020 | - | $3.50 M(+13.1%) |
Dec 2019 | $11.73 M | $3.10 M(-33.2%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2019 | - | $4.64 M(+156.4%) |
Jun 2019 | - | $1.81 M(-21.4%) |
Mar 2019 | - | $2.30 M(+9.1%) |
Dec 2018 | $22.48 M(-36.7%) | $2.11 M(-25.4%) |
Sep 2018 | - | $2.83 M(-69.2%) |
Jun 2018 | - | $9.17 M(+9.5%) |
Mar 2018 | - | $8.38 M(+1.6%) |
Dec 2017 | $35.49 M(-11.8%) | $8.24 M(-14.8%) |
Sep 2017 | - | $9.67 M(+6.7%) |
Jun 2017 | - | $9.07 M(+6.6%) |
Mar 2017 | - | $8.51 M(+4.4%) |
Dec 2016 | $40.23 M(+37.7%) | $8.15 M(-26.7%) |
Sep 2016 | - | $11.11 M(-3.1%) |
Jun 2016 | - | $11.47 M(+20.8%) |
Mar 2016 | - | $9.50 M(+19.8%) |
Dec 2015 | $29.21 M | $7.93 M(-2.9%) |
Sep 2015 | - | $8.17 M(+15.1%) |
Jun 2015 | - | $7.09 M(+17.8%) |
Mar 2015 | - | $6.02 M(+202.1%) |
Sep 2014 | - | $1.99 M(-9.1%) |
Jun 2014 | - | $2.19 M |
FAQ
- What is Salarius Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals annual operating expenses year-on-year change?
- What is Salarius Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals quarterly operating expenses year-on-year change?
What is Salarius Pharmaceuticals annual total operating expenses?
The current annual operating expenses of SLRX is $12.89 M
What is the all time high annual operating expenses for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high annual total operating expenses is $40.23 M
What is Salarius Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, SLRX annual total operating expenses has changed by -$10.08 M (-43.87%)
What is Salarius Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of SLRX is $1.01 M
What is the all time high quarterly operating expenses for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high quarterly total operating expenses is $11.47 M
What is Salarius Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, SLRX quarterly total operating expenses has changed by -$765.10 K (-43.19%)